Figure S1 from Distribution and Activity of Lenvatinib in Brain Tumor Models of Human Anaplastic Thyroid Cancer Cells in Severe Combined Immune Deficient Mice
Supplementary Figure 1 shows the effect of lenvatinib and sorafenib on the viability of human anaplastic thyroid cancer cells in 3D-culture plates in vitro.